Chronic Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: Prevention concepts

被引:0
作者
Dittrich, A. -M. [1 ]
机构
[1] Hannover Med Sch, Klin Padiatr Pneumol Allergol & Neonatol, Carl Neuberg Str 1, D-30625 Hannover, Germany
来源
INTERNIST | 2017年 / 58卷 / 11期
关键词
ERADICATION FAILURE; PULMONARY-FUNCTION; LUNG-FUNCTION; INFECTION; CHILDREN; PREVALENCE; DIAGNOSIS; TOBRAMYCIN; INHALATION; THERAPY;
D O I
10.1007/s00108-017-0327-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pseudomonas aeruginosa (PsA) is a hallmark pathogen of the lung disease in cystic fibrosis (CF) patients. Chronic PsA colonization is a central factor in the course of CF lung disease. PsA contributes considerably to morbidity and mortality, and also has a significant impact on quality of life and the costs of CF treatment. Prevention of chronic colonization has therefore been a major goal in the treatment of CF patients for many years now. In the present article, studies are presented which suggest that prevention of chronic colonization can be achieved. Approaches to prevent chronic PsA colonization are critically evaluated and recommendations for preventative approaches are generated from this discussion. © 2017, Springer Medizin Verlag GmbH.
引用
收藏
页码:1133 / 1141
页数:9
相关论文
共 51 条
  • [1] The Effect of Early Pseudomonas aeruginosa Treatment on Lung Function in Pediatric Cystic Fibrosis
    Amin, Reshma
    Lam, Michelle
    Dupuis, Annie
    Ratjen, Felix
    [J]. PEDIATRIC PULMONOLOGY, 2011, 46 (06) : 554 - 558
  • [2] [Anonymous], PSEUD AER INF PEOPL
  • [3] Effectiveness of a stepwise Pseudomonas aeruginosa eradication protocol in children with cystic fibrosis
    Blanchard, Ana C.
    Horton, Eric
    Stanojevic, Sanja
    Taylor, Louise
    Waters, Valerie
    Ratjen, Felix
    [J]. JOURNAL OF CYSTIC FIBROSIS, 2017, 16 (03) : 395 - 400
  • [4] Respiratory bacterial infections in cystic fibrosis
    Ciofu, Oana
    Hansen, Christine R.
    Hoiby, Niels
    [J]. CURRENT OPINION IN PULMONARY MEDICINE, 2013, 19 (03) : 251 - 258
  • [5] An aerobiological model of aerosol survival of different strains of Pseudomonas aeruginosa isolated from people with cystic fibrosis
    Clifton, I. J.
    Fletcher, L. A.
    Beggs, C. B.
    Denton, M.
    Conway, S. P.
    Peckham, D. G.
    [J]. JOURNAL OF CYSTIC FIBROSIS, 2010, 9 (01) : 64 - 68
  • [6] Eradication failure of newly acquired Pseudomonas aeruginosa isolates in cystic fibrosis
    Cohen-Cymberknoh, Malena
    Gilead, Noa
    Gartner, Silvia
    Rovira, Sandra
    Blau, Hannah
    Mussaffi, Huda
    Rivlin, Joseph
    Gur, Michal
    Shteinberg, Michal
    Bentur, Lea
    Livnat, Galit
    Aviram, Micha
    Picard, Elie
    Tenenbaum, Ariel
    Armoni, Shoshana
    Breuer, Oded
    Shoseyov, David
    Kerem, Eitan
    [J]. JOURNAL OF CYSTIC FIBROSIS, 2016, 15 (06) : 776 - 782
  • [7] Change in Pseudomonas aeruginosa prevalence in cystic fibrosis adults over time
    Crull, Mathew R.
    Ramos, Kathleen J.
    Caldwell, Ellen
    Mayer-Hamblett, Nicole
    Aitken, Moira L.
    Goss, Christopher H.
    [J]. BMC PULMONARY MEDICINE, 2016, 16
  • [8] Doring G, 1996, PEDIATR PULM, V21, P90, DOI 10.1002/(SICI)1099-0496(199602)21:2<90::AID-PPUL5>3.0.CO
  • [9] 2-T
  • [10] Personalised medicine for cystic fibrosis: treating the basic defect
    Elborn, J. Stuart
    [J]. EUROPEAN RESPIRATORY REVIEW, 2013, 22 (127) : 3 - 5